| Authors: |
van der Straten L; Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands.; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands.; Department of Immunology Erasmus MC Rotterdam The Netherlands., Levin MD; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands., Dinnessen MAW; Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands., Visser O; Department of Registration Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands., Posthuma EFM; Department of Internal Medicine Reinier The Graaf Hospital Delft The Netherlands.; Department of Hematology Leiden University Medical Center Leiden The Netherlands., Doorduijn JK; Department of Hematology University Medical Center Rotterdam, Erasmus MC Cancer Institute Rotterdam The Netherlands., Langerak AW; Department of Immunology Erasmus MC Rotterdam The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands., Dinmohamed AG; Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands.; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.; Department of Public Health, Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands.; Department of Hematology, ancer Center Amsterdam, Amsterdam UMC CVrije Universiteit Amsterdam Amsterdam The Netherlands. |
